Iovance Biotherapeutics

Logo Nasdaq
Business / FinanceBy The Motley Fool2023-03-27 19:56:55
What happened Shares of Iovance Biotherapeutics (NASDAQ: IOVA) were up 11% Monday afternoon after the late-stage biotech company announced on Friday that it...

Logo Nasdaq
TechnologyBy Zacks2023-03-30 15:30:36
A month has gone by since the last earnings report for Iovance Biotherapeutics (IOVA). Shares have lost about 9.2% in that time frame, underperforming the...

Logo GlobeNewswire
SciencePress Release2023-04-01 08:30:00
FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared to the active control SAN DIEGO, April 01, 2023...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-04-01 18:55:00
HASS BIO announced their strategic partnership with imes-icore and pritidenta to offer the first and only lithium-disilicate disk solution available in the...

Logo PR Newswire
HealthPress Release2023-03-31 20:15:00
TORRANCE, Calif., March 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the...

Logo PR Newswire
HealthPress Release2023-03-31 10:30:00
Strategic reprioritization of the Company's pipeline to focus on key clinical assets and overall streamlining of corporate structure and workforce, resulting...

Logo GlobeNewswire
SciencePress Release2023-03-31 11:00:00
Instil confirms cash runway beyond 2026 ITIL-306 phase 1 study anticipated to receive CTA clearance from UK MHRA in 2H'2023 Anticipate initial clinical data...

Logo NewsFileCorp
Press Release2023-03-31 13:25:00
New York, New York--(Newsfile Corp. - March 31, 2023) - Starfleet Innotech, Inc. (OTC Pink: SFIO) and European Biological Medicine, Inc. (EBMI) signed an...

Logo Nasdaq
Business / FinanceBy Fintel2023-04-01 06:29:30
On March 31, 2023, Piper Sandler initiated coverage of Immunovant with a Overweight recommendation. Analyst Price Forecast Suggests 56.52% Upside As of March...

Logo GlobeNewswire
SciencePress Release2023-03-24 20:01:00
First TIL Therapy BLA Submission to U.S. Food and Drug Administration SAN CARLOS, Calif., March 24, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc....

Logo Benzinga
Business / FinanceBy Business Wire2023-03-31 14:00:00
Scribe Therapeutics Inc., a molecular engineering company enabling the creation of genetic medicines through its CRISPR by Design approach to genetic...

Logo PR Newswire
HealthPress Release2023-03-31 06:17:00
LUND, Sweden, March 31, 2023 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological...

Logo PR Newswire
HealthPress Release2023-03-28 07:00:00
GENEVA, Switzerland and AMSTERDAM,The Netherlands, March 28, 2023 /PRNewswire/ -- iOnctura, a clinical stage biotechnology company developing breakthrough...

Logo GlobeNewswire
HealthPress Release2023-03-28 10:00:00
Efforts underway to accelerate patient recruitment and a mend protocols to improve patient outcomes. I nterim data readouts for both studies anticipated in...

Logo PR Newswire
HealthPress Release2023-03-31 12:38:00
NEW YORK, March 31, 2023 /PRNewswire/ -- Dr. Mark "Merriwether" Vorderbruggen of Texas -based Medicine Man Plant Co., has won recognition from Plant-Based...

Logo PR Newswire
NEW YORK, March 31, 2023 /PRNewswire/ -- iQSTEL Inc. (OTCQX: IQST) today released a letter to shareholders from CEO Leandro Iglesias addressing key...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-30 12:04:00
Agreement Focuses on in silico and de novo Discovery and Development of Antibodies Against Tumor Microenvironment Targets. Program will Leverage BioStrand's...

Logo Nasdaq
Business / FinanceBy Fintel2023-04-01 06:29:47
On March 31, 2023, Mizuho initiated coverage of Immunocore Holdings with a Buy recommendation. Analyst Price Forecast Suggests 67.32% Upside As of March 30,...

Logo GlobeNewswire
SciencePress Release2023-03-31 18:42:00
Regulated Information Leuven, BE LGIUM, Boston, MA, US March 31, 2023 07.00 PM CET Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-31 21:52:00
Conference Call Scheduled for April 3, 2023, at 9:00 a.m. Eastern Time bioAffinity Technologies, Inc. BIAF BIAFW))), a biotechnology company addressing the...